Sid Labed

10.00 – EQL-988: Expanding Rapid Treatment for Suicidality Beyond Ketamine by EQUULUS Therapeutics

10.15 – Building a Best-in-class Cell Therapy for Parkinson’s Disease by Treefrog Therapeutics

10.30 – First-In-Class Inhibitors of ALOX15 for Agitation in Dementia and Pain by Kinoxis Therapeutics

10.45 – A First-in-Class Intranasal Nanobody for Treatment-Resistant Depression by EvoDenovo

11.00 – Olfactory Neurons as a Longitudinal, Molecular Window into Patient Brain Biology by Crownlands

11.15 – MB-204: A Novel A2a Receptor Antagonist to the Restore Social Reward Signal in Autism, Depression & Alzheimer’s Disease by Marvel Biotechnology

11.30 – Presentation by Beacon Neuroscience